Literature DB >> 10515207

Somatic pairing between subtelomeric chromosome regions: implications for human genetic disease?

K Stout1, S van der Maarel, R R Frants, G W Padberg, H H Ropers, T Haaf.   

Abstract

Fluorescence in-situ hybridization (FISH) has been used to study the spatial orientation of subtelomeric chromosome regions in the interphase nucleus. Compared to interstitial chromosomal sites, subtelomeres showed an increased number of somatic pairings. However, pairing frequency also depended on the specific regions involved and varied both between different subtelomeres and between different interstitial regions. An increased incidence of somatic pairing may play at least some role in the frequent involvement of the subtelomeres in cytogenetically cryptic chromosome rearrangements. In patients suffering from facioscapulohumeral muscular dystrophy (FSHD), which is associated with a deletion of subtelomeric repeats, the FSHD region on 4qter showed a changed pairing behavior, which could be indicative of a position effect and/or trans-sensing effect as a cause for disease.

Entities:  

Mesh:

Year:  1999        PMID: 10515207     DOI: 10.1023/a:1009287111661

Source DB:  PubMed          Journal:  Chromosome Res        ISSN: 0967-3849            Impact factor:   5.239


  29 in total

Review 1.  Trans-sensing effects from Drosophila to humans.

Authors:  K D Tartof; S Henikoff
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

2.  Preferential somatic pairing between homologous heterochromatic regions of human chromosomes.

Authors:  T Haaf; K Steinlein; M Schmid
Journal:  Am J Hum Genet       Date:  1986-03       Impact factor: 11.025

3.  Arrangement of centromeres in mouse cells.

Authors:  T C Hsu; J E Cooper; M L Mace; B R Brinkley
Journal:  Chromosoma       Date:  1971       Impact factor: 4.316

4.  Nucleolar transcriptional activity in mouse Sertoli cells is dependent on centromere arrangement.

Authors:  T Haaf; C Steinlein; M Schmid
Journal:  Exp Cell Res       Date:  1990-11       Impact factor: 3.905

5.  Allele-specific replication timing of imprinted gene regions.

Authors:  D Kitsberg; S Selig; M Brandeis; I Simon; I Keshet; D J Driscoll; R D Nicholls; H Cedar
Journal:  Nature       Date:  1993-07-29       Impact factor: 49.962

6.  FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit.

Authors:  J C van Deutekom; C Wijmenga; E A van Tienhoven; A M Gruter; J E Hewitt; G W Padberg; G J van Ommen; M H Hofker; R R Frants
Journal:  Hum Mol Genet       Date:  1993-12       Impact factor: 6.150

Review 7.  Arrangement of chromatin in the nucleus.

Authors:  D E Comings
Journal:  Hum Genet       Date:  1980-02       Impact factor: 4.132

8.  Reproducible compartmentalization of individual chromosome domains in human CNS cells revealed by in situ hybridization and three-dimensional reconstruction.

Authors:  L Manuelidis; J Borden
Journal:  Chromosoma       Date:  1988       Impact factor: 4.316

9.  Integration of human alpha-satellite DNA into simian chromosomes: centromere protein binding and disruption of normal chromosome segregation.

Authors:  T Haaf; P E Warburton; H F Willard
Journal:  Cell       Date:  1992-08-21       Impact factor: 41.582

Review 10.  Position effect in human genetic disease.

Authors:  D J Kleinjan; V van Heyningen
Journal:  Hum Mol Genet       Date:  1998       Impact factor: 6.150

View more
  15 in total

1.  FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patients.

Authors:  T Rijkers; G Deidda; S van Koningsbruggen; M van Geel; R J L F Lemmers; J C T van Deutekom; D Figlewicz; J E Hewitt; G W Padberg; R R Frants; S M van der Maarel
Journal:  J Med Genet       Date:  2004-11       Impact factor: 6.318

2.  Spatial association of homologous pericentric regions in human lymphocyte nuclei during repair.

Authors:  Shamci Monajembashi; Alexander Rapp; Eberhard Schmitt; Heike Dittmar; Karl-Otto Greulich; Michael Hausmann
Journal:  Biophys J       Date:  2004-12-30       Impact factor: 4.033

Review 3.  The D4Z4 repeat-mediated pathogenesis of facioscapulohumeral muscular dystrophy.

Authors:  Silvère M van der Maarel; Rune R Frants
Journal:  Am J Hum Genet       Date:  2005-01-24       Impact factor: 11.025

Review 4.  Facioscapulohumeral muscular dystrophy as a model for epigenetic regulation and disease.

Authors:  Charis L Himeda; Takako I Jones; Peter L Jones
Journal:  Antioxid Redox Signal       Date:  2014-12-04       Impact factor: 8.401

5.  A novel molecular mechanism in human genetic disease: a DNA repeat-derived lncRNA.

Authors:  Daphne S Cabianca; Valentina Casa; Davide Gabellini
Journal:  RNA Biol       Date:  2012-10-01       Impact factor: 4.652

Review 6.  Epigenetic mechanisms of facioscapulohumeral muscular dystrophy.

Authors:  Jessica C de Greef; Rune R Frants; Silvère M van der Maarel
Journal:  Mutat Res       Date:  2008-08-03       Impact factor: 2.433

7.  Pairing of homologous regions in the mouse genome is associated with transcription but not imprinting status.

Authors:  Christel Krueger; Michelle R King; Felix Krueger; Miguel R Branco; Cameron S Osborne; Kathy K Niakan; Michael J Higgins; Wolf Reik
Journal:  PLoS One       Date:  2012-07-03       Impact factor: 3.240

8.  The 4q subtelomere harboring the FSHD locus is specifically anchored with peripheral heterochromatin unlike most human telomeres.

Authors:  Rose Tam; Kelly P Smith; Jeanne B Lawrence
Journal:  J Cell Biol       Date:  2004-10-25       Impact factor: 10.539

9.  Gene density and transcription influence the localization of chromatin outside of chromosome territories detectable by FISH.

Authors:  Nicola L Mahy; Paul E Perry; Wendy A Bickmore
Journal:  J Cell Biol       Date:  2002-12-09       Impact factor: 10.539

10.  Chromosome loops arising from intrachromosomal tethering of telomeres occur at high frequency in G1 (non-cycling) mitotic cells: Implications for telomere capture.

Authors:  Art Daniel; Luke St Heaps
Journal:  Cell Chromosome       Date:  2004-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.